Connect with us

Business

White House launches direct to consumer drug site

Published

on

White House launches direct to consumer drug site

U.S. President Donald Trump makes an announcement from the Oval Office at the White House in Washington, D.C., U.S. Nov. 6, 2025.

Jonathan Ernst | Reuters

President Donald Trump on Thursday is slated to announce the launch of TrumpRx – a direct-to-consumer website that is key to his administration’s efforts to lower prescription drug costs in the U.S. 

Advertisement

In a post on X, White House press secretary Karoline Leavitt said Trump and other administration officials will debut the new website at 7 p.m. ET on Thursday. 

She said millions of Americans would save money through TrumpRx, but it’s still unclear if all patients – particularly those with insurance coverage – will see more cost savings from using that site to buy their medicines. TrumpRx targets people who are willing to pay with cash and forgo insurance, which suggests that people without or with limited coverage may benefit the most. 

The site is not expected to sell drugs directly to American patients, but will act as a central hub that points them to drugmakers that are offering discounts on certain products on their own direct-to-consumer sites. For example, Eli Lilly and Novo Nordisk have offered their blockbuster obesity drugs at hefty discounts to cash-paying patients. 

In recent months, both companies and at least 14 other drugmakers have negotiated agreements with the Trump administration to participate on the platform and voluntarily sell certain medicines at a discount to Medicaid patients. Those landmark deals are part of Trump’s broader “most favored nation” policy, which pushes to link U.S. drug prices to the lowest ones abroad.

Advertisement

It is the government’s latest effort to try to rein in U.S. prescription drug prices, which are two to three times higher on average than those in other developed nations – and up to 10 times more than in certain countries, according to the Rand Corp., a public policy think tank.

In an exclusive interview with CNBC last week, Eli Lilly CEO Dave Ricks said the company was the first drugmaker to sell obesity treatments directly to patients, and that TrumpRx is “taking that and expanding it across the industry” to other medicines.

“We’re all for that,” Ricks said.

Questions about savings

Advertisement
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Business

Yields Tick Up After Treasury’s Latest Borrowing Plan

Published

on

Yields Tick Up After Treasury's Latest Borrowing Plan

Treasury said it doesn’t plan to change note-and-bond auctions “for at least the next several quarters,” which was as expected.

It also continues to evaluate demand for different Treasurys as it considers increasing future auction sizes.

Using new language, the Treasury said it is monitoring Federal Reserve purchases of short-term Treasury bills and “growing demand for Treasury bills from the private sector.”

That signals officials think that they could lean more on bills for funding than in the past.

Advertisement

In recent trading, the yield on the 10-year Treasury note was 4.286%, according to Tradeweb, up from 4.272% on Tuesday.

Continue Reading

Business

Berkeley file US$1.25b claim against Spain over Salamanca issues

Published

on

Berkeley file US$1.25b claim against Spain over Salamanca issues

A subsidiary of Perth-based uranium miner Berkeley Energia has filed a US$1.25 billion compensation claim against Spain over its hamstrung Salamanca uranium project.

Continue Reading

Business

Bitcoin price hits lowest level since Trump took office

Published

on

Bitcoin price hits lowest level since Trump took office

Bitcoin prices tend to be volatile, but analysts with Deutsche Bank said in a note on Wednesday that the latest drop was “triggered by” Trump’s nomination of Kevin Warsh, as the new chair of the Federal Reserve. Some believe he will take a more “hawkish” approach, keeping interest rates higher, whereas looser monetary policy tends to support investment in assets such as crypto currencies.

Continue Reading

Business

The Czech Tennis Phenom Breaking Into the WTA Top 100

Published

on

10 Must-Know Facts About Sara Bejlek

At only 20 years old, Sara Bejlek has already established herself as one of the most promising young talents on the WTA Tour. The Czech left-hander, once the world’s No. 4 junior, has transitioned to the professional ranks with impressive speed and maturity. In 2026 she sits inside the top 100 for the first time in her career and is widely regarded as the next big breakout star from the tennis powerhouse nation that produced Petra Kvitová, Karolína Plíšková, Barbora Krejčíková and Markéta Vondroušová.

Here are the 10 essential things every tennis fan should know about Sara Bejlek right now.

1. Record-Setting Junior Career

Bejlek was one of the most dominant juniors of her generation. She reached a career-high junior ranking of No. 4 in the world and won four ITF junior titles, including back-to-back Grade 1 titles in 2021 (Czech Indoor and Czech Open). She made the semifinals of the 2022 Australian Open juniors and the quarterfinals of the French Open juniors the same year. Her junior highlight came at the 2021 US Open juniors, where she reached the final before falling to Robin Montgomery.

She turned pro full-time at 16 and never looked back.

Advertisement

2. Fastest Climb to the WTA Top 200

Bejlek cracked the WTA top 200 for the first time in May 2023 at age 17 after winning three consecutive ITF W60 titles on clay (Prerov, Otočec, Prague). She became the youngest Czech woman to reach that milestone since Karolína Muchová in 2015. By the end of 2024 she was ranked No. 139 and in 2025 she finished the year at No. 92—her first top-100 season.

3. Clay-Court Specialist with Serious Power

Bejlek is a classic clay-court player with heavy topspin groundstrokes, excellent movement, and a dangerous lefty forehand that can flatten out into winners. Her average forehand speed on clay exceeds 78 mph, placing her among the fastest-hitting teenagers on tour. She won 78% of her main-draw ITF matches on clay between 2022 and 2025.

She is particularly dangerous when dictating with her forehand from the baseline and using sharp angles to open the court.

4. Breakthrough 2025 Season: First WTA Quarterfinal & Top-100 Finish

2025 was the breakout year. Bejlek reached her first WTA quarterfinal at the Prague Open in July (lost to Linda Nosková), made the third round of the US Open as a qualifier (defeating former top-20 player Elise Mertens), and finished the season inside the top 100 for the first time. She won two ITF W75 titles and reached the final of an ITF W100, posting a 52–19 win-loss record.

Advertisement

5. First WTA-Level Win Over a Top-20 Player

In the second round of the 2025 US Open, Bejlek defeated world No. 18 Elise Mertens 6–4, 7–5 in a tense three-set battle that lasted 2 hours 18 minutes. It was her first victory over a top-20 opponent and the biggest win of her career at the time. She followed it with a gritty third-round loss to eventual semifinalist Jessica Pegula.

6. Mental Toughness & Clutch Play

Bejlek has already shown championship-level composure in deciding sets. In 2025 she won 14 of her last 17 deciding sets and converted 68% of her break points in matches that went the distance. Coaches and opponents frequently praise her “ice-in-the-veins” mentality on big points.

7. Left-Handed Advantage & Serve Potential

As a lefty, Bejlek creates unique angles with her forehand and serve that right-handers find difficult to read. Her first serve averages 105–108 mph and she has been working intensively on adding kick and slice variety to her second serve. Analysts believe her serve could become a significant weapon once she adds more consistency and placement.

8. Czech Tennis Factory Continues to Produce

Bejlek is the latest product of the Czech tennis development system that has produced more Grand Slam champions per capita than any other nation over the last 15 years. She trains at the Prague Tennis Academy under coach David Škoch (former Davis Cup player) and frequently practices with Karolína Muchová and Linda Nosková. The Czech Republic now has six women ranked inside the top 100 in early 2026 — the most of any country outside the United States.

Advertisement

9. Off-Court Personality & Growing Brand

Bejlek is known for her dry humor, love of heavy metal music (she has Metallica and Slipknot tattoos), and candid interviews. She frequently engages with fans on social media and has built a loyal following in Central Europe. Her signature celebration—a quick double fist-pump followed by a point to the sky—has become recognizable.

She signed endorsement deals with Nike, Babolat, and a Czech energy-drink brand in 2025 and is starting to appear in fashion campaigns in Prague.

10. 2026 Goals: Top 50, First WTA Title & Grand Slam Fourth Round

Entering the 2026 season ranked No. 92, Bejlek is projected by most analysts to finish the year inside the top 50. Her goals are clear: win her first WTA title, reach the fourth round of a Grand Slam, and break into the top 40. With a healthy clay-court swing (she excels in Europe’s spring swing) and continued improvement on hard courts, many believe 2026 could be the year she truly announces herself as a top-30 player.

Advertisement
Continue Reading

Business

Canada unveils auto industry plan in latest pivot away from US

Published

on

Canada unveils auto industry plan in latest pivot away from US

The steps to bolster Canada’s auto industry come as Trump’s tariffs strain the sector and threaten jobs.

Continue Reading

Business

Illumina, Inc. (ILMN) Q4 2025 Earnings Call Transcript

Published

on

OneWater Marine Inc. (ONEW) Q1 2026 Earnings Call Transcript

Illumina, Inc. (ILMN) Q4 2025 Earnings Call February 5, 2026 4:30 PM EST

Company Participants

Conor Noel McNamara – VP of Investor Relations
Jacob Thaysen – CEO, Interim Chief Commercial Officer & Director
Ankur Dhingra – Chief Financial Officer

Conference Call Participants

Advertisement

Douglas Schenkel – Wolfe Research, LLC
Vijay Kumar – Evercore ISI Institutional Equities, Research Division
Puneet Souda – Leerink Partners LLC, Research Division
Tycho Peterson – Jefferies LLC, Research Division
Michael Ryskin – BofA Securities, Research Division
Kyle Mikson – Canaccord Genuity Corp., Research Division
Daniel Arias – Stifel, Nicolaus & Company, Incorporated, Research Division
Jack Meehan – Nephron Research LLC
Casey Woodring – JPMorgan Chase & Co, Research Division
David Westenberg – Piper Sandler & Co., Research Division
Subhalaxmi Nambi – Guggenheim Securities, LLC, Research Division

Presentation

Operator

Advertisement

Good day, ladies and gentlemen. Welcome to the Fourth Quarter 2025 Illumina Earnings Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to hand the call over to Head of Investor Relations, Conor McNamara.

Conor Noel McNamara
VP of Investor Relations

Hello, everyone, and welcome to Illumina’s Fourth Quarter 2025 Earnings Call. Today, we will review our financial results released after the market close and provide prepared remarks before opening the line for Q&A. Our earnings release is available in the Investor Relations section of illumina.com. Joining us on today’s call are Jacob Thaysen, Chief Executive Officer; and Ankur Dhingra, Chief Financial Officer. Jacob will start with an update on Illumina’s business, followed by Ankur’s review of the company’s financials.

Advertisement

We will be discussing certain non-GAAP financial measures on today’s call, and a reconciliation to GAAP can be found in today’s release and in the supplementary data available on our website. Please note that unless otherwise stated or when referring to end markets, all year-over-year revenue growth rates discussed in our prepared remarks are

Advertisement
Continue Reading

Business

J&J Snack stock takes dive

Published

on

J&J Snack stock takes dive

Share price plummets 15% after disappointing sales.

Continue Reading

Business

Can robots ever be graceful?

Published

on

Can robots ever be graceful?

Firms are working to make the motors that drive robots more efficient and cheaper.

Continue Reading

Business

Jennifer Garner’s Once Upon a Farm raises nearly $198 million in US IPO

Published

on

Jennifer Garner’s Once Upon a Farm raises nearly $198 million in US IPO


Jennifer Garner’s Once Upon a Farm raises nearly $198 million in US IPO

Continue Reading

Business

Wall Street ends sharply down as AI worries weigh

Published

on

Wall Street ends sharply down as AI worries weigh

Wall Street ended sharply lower on Thursday, with the Nasdaq dragged to its ‍lowest since November by losses in Microsoft, Amazon and other tech heavyweights after Alphabet said it could double capital spending on AI in the race to dominate the ​emerging technology.

Continue Reading

Trending

Copyright © 2025